Treatment-Associated Reduction in Detectable Aspergillus DNA Following N-Alkylbenzimidazole Exposure in Infected Drosophila melanogaster
Williams Burke Ghate *
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Jos, Jos, Nigeria.
Ikoni Joshua Ogaji
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Jos, Jos, Nigeria.
Ponchang Apollos Wuyep
Department of Plant Science and Biotechnology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Introduction: Invasive aspergillosis caused by Aspergillus species remains a major cause of fungal morbidity and mortality, while the emergence of azole-resistant isolates has intensified the search for alternative antifungal agents. N-alkylbenzimidazole derivatives have demonstrated promising antifungal properties, but evidence of their therapeutic potential in living host systems remains limited.
Aim: This study evaluated the In vitro antifungal activity, In vivo toxicity, and therapeutic efficacy of selected N-alkylbenzimidazole derivatives against Aspergillus species using Drosophila melanogaster as an infection model, alongside assessment of treatment-associated changes in fungal DNA detectability.
Study Design: An experimental laboratory study involving antifungal susceptibility testing, toxicity assessment, survival analysis, and qualitative molecular detection was conducted.
Methodology: Clinical isolates of A. niger and A. flavus were tested against N-alkylbenzimidazole chlorobenzyl and N-alkylbenzimidazole dimercaptoacrylonitrile using agar diffusion assays at different concentrations. Fly toxicity was evaluated using probit analysis, while therapeutic efficacy was assessed in infected D. melanogaster (Drs-LacZ), with survival monitored for seven days post-infection. Fungal DNA detectability was investigated using conventional polymerase chain reaction targeting the internal transcribed spacer (ITS1–5.8S–ITS2) region, followed by agarose gel electrophoresis.
Results: Both derivatives inhibited the two Aspergillus species in a concentration-dependent manner, with inhibition zones at 100 µg/mL comparable to or greater than those of itraconazole. The derivatives exhibited relatively low toxicity, with a reported median lethal concentration (LC₅₀) of approximately 136 µg/mL. Treatment significantly prolonged the survival of infected flies compared with infected untreated controls. PCR analysis revealed reduced detectability of Aspergillus DNA at higher treatment concentrations in some groups, whereas other groups retained faint or progressively stronger amplicons at lower concentrations, indicating variation in treatment response.
Conclusion: The findings demonstrate promising antifungal activity and preliminary therapeutic potential of the tested N-alkylbenzimidazole derivatives in a Drosophila infection model.
Keywords: N-alkylbenzimidazole derivatives, Aspergillus, Drosophila melanogaster, internal transcribed spacer, PCR